Guerbet announces marketing authorisation approval of Elucirem™ (Gadopiclenol) in the European Union
(Adnkronos) – VILLEPINTE, France, Dec. 11, 2023 /PRNewswire/ — Guerbet, global leader in contrast products for medical imaging, announced today that the European Commission has approved the marketing in the European Union
